It is hoped the new formulation will offer patients greater freedom and flexibility compared to the liquid version ...

Apogee Therapeutics has shared positive 16-week results from a mid-stage study of its investigational anti-IL-13 antibody in ...

Patient engagement is one of the most reliable ways to drive long-term health outcomes and a critical benchmark for ...

Japan’s evolving approach to market access includes a formal cost-effectiveness analysis (CEA) requirement for certain new ...